| Literature DB >> 17692830 |
Kunio Kitahama1, Michel Geffard, Silvia Araneda, Ryohachi Arai, Keiko Ogawa, Ikuko Nagatsu, Jean-Marc Pequignot.
Abstract
The present study examined dopamine-immunoreactive neuronal structures using immunohistochemistry in conjunction with an anti-dopamine antiserum, following injection of l-3,4-dihydroxyphenylalanine (L-DOPA) with or without an inhibitor of monoamine oxidase (Pargyline) in the cat brain. L-DOPA injection made it possible to detect dopamine immunoreactivity in presumptive serotonergic and noradrenergic cell bodies and axons. Weak to moderate dopamine immunoreactivity was observed in non-aminergic cells (possibly so-called "D" cells containing aromatic L-amino acid decarboxylase (AADC)) in several hypothalamic, midbrain, pontine and medullary nuclei. Intense dopamine immunoreactivity became visible in a large number of cells and axons (possibly containing AADC) with wide distribution in the brain following administration of L-DOPA with Pargyline. AADC is most likely active in cells and axons that take up L-DOPA, where it decarboxylates the L-DOPA to dopamine. However, newly synthesized dopamine in such cells is rapidly oxidized by monoamine oxidase.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17692830 DOI: 10.1016/j.brainres.2007.05.081
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252